Inhibition of thrombin attenuates stenosis after arterial injury in minipigs

Journal of the American College of Cardiology

Volumn 28, Issue 7, 1997, Pages 1849-1855

  Abendschein, Dana R ^a   Recchia, Dino ^b   Meng, Yuan Yuan ^b   Oltrona, Luigi ^a   Wickline, Samuel A ^a   Eisenberg, Paul R ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DESULFATOHIRUDIN; HEPARIN; RECOMBINANT TICK ANTICOAGULANT PEPTIDE; THROMBIN; THROMBIN INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; SWINE;

ANGIOPLASTY, BALLOON; ANIMALS; ANTICOAGULANTS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CAROTID STENOSIS; FACTOR XA; HEPARIN; HIRUDINS; HYPERCHOLESTEROLEMIA; MALE; PARTIAL THROMBOPLASTIN TIME; PEPTIDES; PROTHROMBIN; RECOMBINANT PROTEINS; SWINE; SWINE, MINIATURE; THROMBIN; TUNICA INTIMA;

EID: 0030473882     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00362-2     Document Type: Article

References (36)

1. Ip JH, Fuster V, Israel D, Badimon L, Badimon J, Chesebro JH. The role of platelets, thrombin, and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 1991;17 Suppl B:77B-88B.
2. Holmes D, Schwartz R, Webster M. Coronary restenosis: what have we learned from angiography? J Am Coll Cardiol 1991;17 Suppl B:14B-22B.
3. Bell MR, Gersh BJ. Restenosis: a clinician's perspective. In: Schwartz RS, editor. Coronary Restenosis. Cambridge (MA): Blackwell Scientific, 1993:15.
4. Chesebro JH, Badimon L, Fuster V. Importance of antithrombin therapy during coronary angioplasty. J Am Coll Cardiol 1991;17 Suppl B:96B-100B.
5. Lee PC, Gibbons GH, Dzau VJ. Cellular and molecular mechanisms of coronary artery restenosis. Coron Artery Dis 1993;4:254-9.
6. Berk BC, Taubman MB, Cragoe EJ Jr, Fenton JW II, Griendling KK. Thrombin signal transduction mechanisms in rat vascular smooth muscle cells. J Biol Chem 1990;265:17334-40.
7. Wilcox JN, Rodriguez J, Subramanian R, et al. Characterization of thrombin receptor expression during vascular lesion formation. Circ Res 1994;75:1029-38.
8. Ellis SG, Roubin GS, Wilentz J, Douglas JS, King SB III. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989;117:772-82.
9. Laskey MA, Deutsch E, Hirshfeld JW Jr, Kussmaul WG, Barnathan E, Laskey WK. Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombus. Am J Cardiol 1990;65:179-82.
10. Sarembock IJ, Gertz SD, Gimple LW, Owen RM, Powers ER, Roberts WC. Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 1991;84:232-43.
11. Unterberg C, Sandrock D, Nebendahl K, Buchwald AB. Reduced acute thrombus formation results in decreased neointimal proliferation after coronary angioplasty. J Am Coll Cardiol 1995;26:1747-54.
12. Serruys PW, Herrman J-PR, Simon R, et al., for the Helvetica Investigators. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. N Engl J Med 1995;333:757-63.
13. Mann KG, Tracey PB, Nesheim ME. Assembly and function of prothrombinase complexes on synthetic and natural membranes. In: Oates JA, Harwiger J, Ross R, editors. Interaction of Platelets with the Vessel Wall. Washington (DC): American Physiological Society, 1985:47.
14. Rapaport SE, Schiffman S, Patch MJ, Ames SB. The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin on the generation of intrinsic prothrombinase activity. Blood 1963;21:221-36.
15. Gailani D, Broze GJ Jr. Factor XI activation in a revised model of blood coagulation. Science 1991;253:909-12.
16. Recchia D, Abendschein DR, Saffitz JE, Wickline SA. The biological behavior of balloon hyperinflation-induced arterial lesions in hypercholesterolemic pigs depends on the presence of foam cells. Arterioscler Thromb Vasc Biol 1995;15:924-9.
17. Waxman L, Smith DE, Arcuri KE, Vlasuk GP. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science 1990;248:593-6.
18. Steele PM, Chesebro JH, Stanson AW, et al. Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model. Circ Res 1985;57:105-12.
19. Walters TK, Gorog DA, Wood RFM. Thrombin generation following arterial injury is a critical initiating event in the pathogenesis of the proliferative stages of the atherosclerotic process. J Vasc Res 1994;31:173-77.
20. Essed CE, van der Braud M, Becker AE. Transluminal coronary angioplasty and early restenosis: fibrocellular occlusion after wall laceration. Br Heart J 1983;49:393-6.
21. Johnson DE, Hinohara T, Selmon MR, Braden LJ, Simpson JB. Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: a histopathologic study. J Am Coll Cardiol 1990;15:419-25.
22. Heras M, Chesebro JH, Penny WJ, Bailey KR, Badimon L, Fuster V. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation 1989;79:657-65.
23. Naito M, Hayashi T, Kuzuya M, Runaki C, Assi K, Kuzuya F. Effects of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro. Atherosclerosis 1990;83:9-14.
24. Ross R. Platelet-derived growth factor. Lancet 1989;1:1179-82.
25. Ferns GA, Raines EW, Sprugel KH, Montani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle cell accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129-32.
26. Bar-Shavit R, Kahn A, Wilner GD, Fenton JW. Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science 1983;220:728-31.
27. Ragosta M, Barry WL, Gimple LW, et al. Effect of thrombin inhibition with desulfatohirudin on early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbits. Circulation 1996;93:1194-1200.
28. Hatton MWC, Moar SL, Richardson M. Deendothelialization in vivo initiates a thrombogenic reaction at the rabbit aorta surface. Correlation of uptake of fibrinogen and antithrombin III with thrombin generation by the exposed subendothelium. Am J Pathol 1989;135:499-508.
29. Speidel CM, Eisenberg PR, Ruf W, Edgington TS, Abendschein DR. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon injured aortas in rabbits. Circulation 1995;92:3323-30.
30. Agnelli G, Renga C, Weitz JI, Nenci GG, Hirsh J. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin. Blood 1992;80:960-5.
31. Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990;86:385-91.
32. Ragosta M, Gimple LW, Gertz SD, et al. Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 1994;89:1262-71.
33. Waxman L, Smith DE, Arcuri KE, Vlasuk GP. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science 1990;248:593-6.
34. Reitman JS, Mahley RW, Fry DL. Yucatan miniature swine as a model for diet-induced atherosclerosis. Atherosclerosis 1982;43:119-24.
35. Kohchi K, Takebayashi S, Block PC, Hiroki T, Nobuyoshi M. Arterial changes after percutaneous coronary angioplasty: results at autopsy. J Am Coll Cardiol 1987;10:592-9.
36. Fernandex-Ortiz A, Meyer BJ, Mailhac A, et al. A new approach for local intravascular drug delivery: iontophoretic balloon. Circulation 1994;89:1518-22.